Factors influencing ovarian cancer survival after chemotherapy

M J Webb, G D Malkasian, E O Jorgensen
Obstetrics and gynecology · 1974 · PMID:4413425
other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This study identified key factors that influenced ovarian cancer patient survival following chemotherapy treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cystadenocarcinoma Endometriosis Mesonephroma Ovarian Neoplasms Antibody Formation Antineoplastic Agents Antineoplastic Agents Body Weight Cyclophosphamide Cyclophosphamide Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-14T05:59:03.573854+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine